Expanding the CRISPR/Cas9 toolkit for Pichia pastoris with efficient donor integration and alternative resistance markers
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
29091307
PubMed Central
PMC5887973
DOI
10.1002/jcb.26474
Knihovny.cz E-resources
- Keywords
- CRISPR/Cas9, KU70, Pichia pastoris, homologous recombination, marker recycling, resistance markers,
- MeSH
- CRISPR-Cas Systems MeSH
- Genetic Engineering MeSH
- Genetic Markers MeSH
- Gene Knockout Techniques methods MeSH
- INDEL Mutation MeSH
- DNA End-Joining Repair MeSH
- Pichia genetics growth & development MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Genetic Markers MeSH
Komagataella phaffii (syn. Pichia pastoris) is one of the most commonly used host systems for recombinant protein expression. Achieving targeted genetic modifications had been hindered by low frequencies of homologous recombination (HR). Recently, a CRISPR/Cas9 genome editing system has been implemented for P. pastoris enabling gene knockouts based on indels (insertion, deletions) via non-homologous end joining (NHEJ) at near 100% efficiency. However, specifically integrating homologous donor cassettes via HR for replacement studies had proven difficult resulting at most in ∼20% correct integration using CRISPR/Cas9. Here, we demonstrate the CRISPR/Cas9 mediated integration of markerless donor cassettes at efficiencies approaching 100% using a ku70 deletion strain. The Ku70p is involved in NHEJ repair and lack of the protein appears to favor repair via HR near exclusively. While the absolute number of transformants in the Δku70 strain is reduced, virtually all surviving transformants showed correct integration. In the wildtype strain, markerless donor cassette integration was also improved up to 25-fold by placing an autonomously replicating sequence (ARS) on the donor cassette. Alternative strategies for improving donor cassette integration using a Cas9 nickase variant or reducing off targeting associated toxicity using a high fidelity Cas9 variant were so far not successful in our hands in P. pastoris. Furthermore we provide Cas9/gRNA expression plasmids with a Geneticin resistance marker which proved to be versatile tools for marker recycling. The reported CRSIPR-Cas9 tools can be applied for modifying existing production strains and also pave the way for markerless whole genome modification studies in P. pastoris.
Bisy e U Wetzawinkel Hofstätten Raab Austria
Department of Biotechnology University of Chemistry and Technology Prague Prague Czech Republic
Institute of Molecular Biotechnology Graz University of Technology Graz Austria
See more in PubMed
Sander JD, Joung JK. CRISPR‐Cas systems for editing, regulating and targeting genomes. Nat Biotechnol. 2014; 32:347–355. PubMed PMC
Wang H, La Russa M, Qi LS. CRISPR/Cas9 in genome editing and beyond. Ann Rev Biochem. 2016; 85:227–264. PubMed
Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR‐Cas9. Science. 2014; 346:1258096. PubMed
Xue W, Chen S, Yin H, et al. CRISPR‐mediated direct mutation of cancer genes in the mouse liver. Nature. 2014; 514:380–384. PubMed PMC
Matano M, Date S, Shimokawa M, et al. Modeling colorectal cancer using CRISPR‐Cas9‐mediated engineering of human intestinal organoids. Nat Med. 2015; 21:256–262. PubMed
Wu Y, Liang D, Wang Y, et al. Correction of a genetic disease in mouse via use of CRISPR‐Cas9. Cell Stem Cell. 2013; 13:659–662. PubMed
Baltimore D, Berg P, Botchan M, et al. Biotechnology. A prudent path forward for genomic engineering and germline gene modification. Science 2015; 348:36–38. PubMed PMC
Roointan A, Morowvat MH. Road to the future of systems biotechnology: CRISPR‐Cas‐mediated metabolic engineering for recombinant protein production. Biotechnol Genet Eng Rev. 2016; 32:74–91. PubMed
Krappmann S. CRISPR‐Cas9, the new kid on the block of fungal molecular biology. Med Mycol. 2017;55:16–23. PubMed
Shen C‐C, Sung L‐Y, Lin S‐Y, Lin M‐W, Hu Y‐C. Enhancing protein production yield from chinese hamster ovary cells by CRISPR interference. ACS Synth Biol. 2017; 6:1509–1519. PubMed
Park G, Ouyang S, Borkovich KA. High‐throughput construction of genetically modified fungi In: Schmoll M, Dattenböck C, editors. Gene Expression systems in fungi: advancements and applications. Cham: Springer International Publishing; 2016:pp 241–252.
Weninger A, Killinger M, Vogl T. Key methods for synthetic biology: genome engineering and DNA assembly In: Glieder A, Kubicek CP, Mattanovich D, Wiltschi B, Sauer M, editors. Synthetic biology. Vol 8 Cham: Springer International Publishing; 2016:pp 101–141.
Gaj T, Gersbach CA, Barbas CF. ZFN, TALEN, and CRISPR/Cas‐based methods for genome engineering. Trends Biotechnol. 2013; 31:397–405. PubMed PMC
Kim H, Kim J‐S. A guide to genome engineering with programmable nucleases. Nat Rev Genet. 2014; 15:321–334. PubMed
Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual‐RNA‐guided DNA endonuclease in adaptive bacterial immunity. Science. 2012; 337:816–821. PubMed PMC
Ma D, Liu F. Genome editing and its applications in model organisms. Genomics Proteomics Bioinformatics. 2015; 13:336–344. PubMed PMC
Kumar V, Jain M. The CRISPR‐Cas system for plant genome editing: advances and opportunities. J Exp Bot. 2015; 66:47–57. PubMed
Kleinstiver BP, Pattanayak V, Prew MS, et al. High‐fidelity CRISPR‐Cas9 nucleases with no detectable genome‐wide off‐target effects. Nature. 2016; 529:490. PubMed PMC
Slaymaker IM, Gao LY, Zetsche B, Scott DA, Yan WX, Zhang F. Rationally engineered Cas9 nucleases with improved specificity. Science. 2016; 351:84–88. PubMed PMC
Bill RM. Playing catch‐up with Escherichia coli: using yeast to increase success rates in recombinant protein production experiments. Front Microbiol. 2014; 5:85. PubMed PMC
Cregg JM, Cereghino JL, Shi J, Higgins DR. Recombinant protein expression in Pichia pastoris . Mol Biotechnol. 2000; 16:23–52. PubMed
Ahmad M, Hirz M, Pichler H, Schwab H. Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production. Appl Microbiol Biotechnol. 2014; 98:5301–5317. PubMed PMC
Näätsaari L, Mistlberger B, Ruth C, Hajek T, Hartner FS, Glieder A. Deletion of the Pichia pastoris KU70 homologue facilitates platform strain generation for gene expression and synthetic biology. PLoS ONE. 2012; 7:e39720. PubMed PMC
Smih F, Rouet P, Romanienko PJ, Jasin M. Double‐strand breaks at the target locus stimulate gene targeting in embryonic stem cells. Nucleic Acids Res. 1995; 23:5012–5019. PubMed PMC
Storici F, Durham CL, Gordenin DA, Resnick MA. Chromosomal site‐specific double‐strand breaks are efficiently targeted for repair by oligonucleotides in yeast. Proc Natl Acad Sci USA. 2003; 100:14994–14999. PubMed PMC
Caldecott KW. Single‐strand break repair and genetic disease. Nat Rev Genet. 2008; 9:619–631. PubMed
Jacobs JZ, Ciccaglione KM, Tournier V, Zaratiegui M. Implementation of the CRISPR‐Cas9 system in fission yeast. Nat Commun. 2014; 5:1–5. PubMed PMC
Horwitz AA, Walter JM, Schubert MG, et al. Efficient multiplexed integration of synergistic alleles and metabolic pathways in yeasts via CRISPR‐Cas. Cell Syst. 2015; 1:88–96. PubMed
Vyas VK, Barrasa MI, Fink GR. A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families. Sci Adv. 2015; 1:e1500248. PubMed PMC
Min K, Ichikawa Y, Woolford CA, Mitchell AP. Candida albicans gene deletion with a transient CRISPR‐Cas9 system. mSphere. 2015; 1:1–9. PubMed PMC
Enkler L, Richer D, Marchand AL, Ferrandon D, Jossinet F. Genome engineering in the yeast pathogen Candida glabrata using the CRISPR‐Cas9 system. Sci Rep. 2016; 6:35766. PubMed PMC
Weninger A, Hatzl A‐M, Schmid C, Vogl T, Glieder A. Combinatorial optimization of CRISPR/Cas9 expression enables precision genome engineering in the methylotrophic yeast Pichia pastoris . J Biotechnol. 2016; 235:139–149. PubMed
Cregg JM, Barringer KJ, Hessler AY, Madden KR. Pichia pastoris as a host system for transformations. Mol Cell Biol. 1985; 5:3376–3385. PubMed PMC
Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR‐Cas9 for genome engineering. Cell. 2014; 157:1262–1278. PubMed PMC
Ran FA, Hsu PD, Lin C, et al. Double nicking by RNA‐guided CRISPR Cas9 for enhanced genome editing specificity. Cell. 2013; 154:1380–1389. PubMed PMC
Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013; 339:819–823. PubMed PMC
Hsu PD, Scott DA, Weinstein JA, et al. DNA targeting specificity of RNA‐guided Cas9 nucleases. Nat Biotechnol. 2013; 31:827–832. PubMed PMC
Sturmberger L, Chappell T, Geier M, et al. Refined Pichia pastoris reference genome sequence. J Biotechnol. 2016; 235:121–131. PubMed PMC
Krainer FW, Gmeiner C, Neutsch L, et al. Knockout of an endogenous mannosyltransferase increases the homogeneity of glycoproteins produced in Pichia pastoris . Sci Rep. 2013; 3:3279. PubMed PMC
Gibson DG, Young L, Chuang R, Venter JC, Hutchison CA, Smith HO. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods. 2009; 6:343–345. PubMed
Weninger A, Glieder A, Vogl T. A toolbox of endogenous and heterologous nuclear localization sequences for the methylotrophic yeast Pichia pastoris . Ah Kang H., ed. FEMS Yeast Res. 2015; 15:p.fov082. PubMed PMC
Vogl T, Sturmberger L, Kickenweiz T, et al. A toolbox of diverse promoters related to methanol utilization: functionally verified parts for heterologous pathway expression in Pichia pastoris . ACS Synth Biol. 2016; 5:172–186. PubMed
Lieber MR. NHEJ and its backup pathways in chromosomal translocations. Nat Struct Mol Biol. 2010; 17:393–395. PubMed PMC
Bétermier M, Bertrand P, Lopez BS. Is non‐homologous end‐joining really an inherently error‐prone process? PLoS Genetics 2014; 10:e1004086. PubMed PMC
Brunet E, Simsek D, Tomishima M, et al. Chromosomal translocations induced at specified loci in human stem cells. Proc Natl Acad Sci USA. 2009; 106:10620–10625. PubMed PMC
Gao S, Tong Y, Wen Z, et al. Multiplex gene editing of the Yarrowia lipolytica genome using the CRISPR‐Cas9 system. J Ind Microbiol Biotechnol. 2016; 43:1085–1093. PubMed
Schwartz CM, Shabbir‐Hussain M, Blenner M, Wheeldon I. Synthetic RNA polymerase III promoters facilitate high‐efficiency CRISPR‐Cas9‐mediated genome editing in Yarrowia lipolytica . ACS Synth Biol. 2016; 5:356–359. PubMed
Saffran WA, Greenberg RB, Thaler‐scheer MS, Jones MM. Single strand and double strand DNA damage‐induced reciprocal recombination in yeast. Dependence on nucleotide excision repair and RAD1 recombination. Nucleic Acids Res. 1994; 22:2823–2829. PubMed PMC
Tsakraklides V, Brevnova E, Stephanopoulos G, Shaw AJ. Improved gene targeting through cell cycle synchronization. PLoS ONE. 2015; 10:1–11. PubMed PMC
Anders C, Niewoehner O, Duerst A, Jinek M. Structural basis of PAM‐dependent target DNA recognition by the Cas9 endonuclease. Nature. 2014; 513:569–573. PubMed PMC
Krainer FW, Dietzsch C, Hajek T, Herwig C, Spadiut O, Glieder A. Recombinant protein expression in Pichia pastoris strains with an engineered methanol utilization pathway. Microb Cell Fact. 2012; 11:22. PubMed PMC
Vogl T, Glieder A. Regulation of Pichia pastoris promoters and its consequences for protein production. New Biotechnol. 2013; 30:385–404. PubMed
Geier M, Brandner C, Strohmeier GA, Hall M, Hartner FS, Glieder A. Engineering Pichia pastoris for improved NADH regeneration: a novel chassis strain for whole‐cell catalysis. Beilstein J Org Chem. 2015; 11:1741–1748. PubMed PMC
Vogl T, Hartner FS, Glieder A. New opportunities by synthetic biology for biopharmaceutical production in Pichia pastoris . Curr Opin Biotechnol. 2013; 24:1094–1101. PubMed PMC
Maruyama T, Dougan SK, Truttmann MC, Bilate AM, Ingram JR, Ploegh HL. Increasing the efficiency of precise genome editing with CRISPR‐Cas9 by inhibition of nonhomologous end joining. Nat Biotech. 2015; 33:538–542. PubMed PMC